MALESCI, ALBERTO CARLO PIERO
 Distribuzione geografica
Continente #
NA - Nord America 3.561
EU - Europa 3.547
AS - Asia 3.275
SA - Sud America 1.026
AF - Africa 87
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 3
AN - Antartide 1
Totale 11.510
Nazione #
US - Stati Uniti d'America 3.392
RU - Federazione Russa 2.074
SG - Singapore 1.021
CN - Cina 982
BR - Brasile 837
VN - Vietnam 383
HK - Hong Kong 356
IT - Italia 306
RO - Romania 287
SE - Svezia 269
FR - Francia 183
BD - Bangladesh 168
GB - Regno Unito 111
DE - Germania 97
IN - India 85
AR - Argentina 76
CA - Canada 74
FI - Finlandia 61
ID - Indonesia 50
MX - Messico 46
JP - Giappone 34
NL - Olanda 30
TR - Turchia 30
AT - Austria 29
EC - Ecuador 26
PK - Pakistan 24
IQ - Iraq 23
PL - Polonia 21
CO - Colombia 20
ZA - Sudafrica 20
PY - Paraguay 19
ES - Italia 18
UA - Ucraina 16
UZ - Uzbekistan 16
CL - Cile 15
VE - Venezuela 15
DZ - Algeria 13
EG - Egitto 13
MY - Malesia 13
MA - Marocco 12
SA - Arabia Saudita 12
IL - Israele 11
UY - Uruguay 11
IE - Irlanda 10
JM - Giamaica 10
AE - Emirati Arabi Uniti 9
AU - Australia 9
HN - Honduras 7
CR - Costa Rica 6
JO - Giordania 6
KE - Kenya 6
KR - Corea 6
LT - Lituania 6
PE - Perù 6
TN - Tunisia 6
TW - Taiwan 6
BE - Belgio 5
CI - Costa d'Avorio 5
PH - Filippine 5
TH - Thailandia 5
CD - Congo 4
KZ - Kazakistan 4
NI - Nicaragua 4
OM - Oman 4
TT - Trinidad e Tobago 4
AZ - Azerbaigian 3
BB - Barbados 3
BY - Bielorussia 3
CH - Svizzera 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
GT - Guatemala 3
NP - Nepal 3
RS - Serbia 3
XK - ???statistics.table.value.countryCode.XK??? 3
AO - Angola 2
BG - Bulgaria 2
BS - Bahamas 2
BZ - Belize 2
DK - Danimarca 2
IR - Iran 2
KG - Kirghizistan 2
KW - Kuwait 2
MM - Myanmar 2
PR - Porto Rico 2
PT - Portogallo 2
SI - Slovenia 2
AL - Albania 1
AM - Armenia 1
AQ - Antartide 1
BF - Burkina Faso 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CG - Congo 1
CU - Cuba 1
CY - Cipro 1
ET - Etiopia 1
GA - Gabon 1
LK - Sri Lanka 1
Totale 11.499
Città #
Moscow 464
Singapore 460
Dallas 406
Ashburn 368
Hong Kong 347
San Jose 214
Beijing 200
New York 164
Ho Chi Minh City 157
Lauterbourg 147
Hefei 119
Shanghai 114
Los Angeles 112
Lawrence 96
Princeton 94
Hanoi 91
São Paulo 68
Santa Clara 55
Helsinki 52
Orem 51
Atlanta 49
Milan 37
San Francisco 36
Chicago 34
Brooklyn 32
Houston 29
London 28
Council Bluffs 27
Denver 27
Montreal 26
Rio de Janeiro 26
Brasília 20
Munich 20
Nuremberg 20
Phoenix 20
Tokyo 20
Rome 18
Warsaw 18
Delhi 17
Seattle 17
Manchester 15
Poplar 15
Porto Alegre 14
Salvador 14
Belo Horizonte 13
Chennai 13
Guangzhou 13
Tashkent 13
Buenos Aires 12
Buffalo 12
Campinas 12
Curitiba 12
Frankfurt am Main 12
Mexico City 12
Xi'an 12
Boardman 11
Haiphong 11
Naples 11
Quito 11
Stockholm 11
Toronto 11
Vienna 11
Calgary 10
Guarulhos 10
Johannesburg 10
Montevideo 10
Mumbai 10
Palermo 10
Philadelphia 10
Ribeirão Preto 10
Ankara 9
Baghdad 9
Boston 9
Da Nang 9
Hangzhou 9
Hải Dương 9
Jakarta 9
The Dalles 9
Tianjin 9
Washington 9
Amsterdam 8
Guayaquil 8
Lahore 8
Thái Bình 8
Asunción 7
Barnet 7
Bologna 7
Cairo 7
Changsha 7
Omaha 7
Santiago 7
Santo André 7
Sumaré 7
Turku 7
Baltimore 6
Bari 6
Can Tho 6
Charlotte 6
Cuiabá 6
Dublin 6
Totale 4.879
Nome #
Prospective comparison of computed tomography enterography and magnetic resonance enterography for assessment of disease activity and complications in ileocolonic Crohn's disease 1.742
Delphi Initiative for Early-Onset Colorectal Cancer (DIRECt) International Management Guidelines 445
Inflammation and coagulation in inflammatory bowel disease: The clot thickens 195
New Drug Delivery Systems in Inflammatory Bowel Disease: MMX (TM) and Tailored Delivery to the Gut 174
The Endoscopic Management of Zenker’s Diverticulum: A Comprehensive Review 151
Budesonide : teaching an old dog new tricks for inflammatory bowel disease treatment 139
Prediction of the First Variceal Hemorrhage in Patients with Cirrhosis of the Liver and Esophageal Varices 135
Critical role of the CD40-CD40-ligand pathway in regulating mucosal inflammation-driven angiogenesis in inflammatory bowel disease 118
Adalimumab in Crohn's disease : tips and tricks after 5 years of clinical experience 117
Unraveling the pathogenesis of Barrett’s esophagus and esophageal adenocarcinoma: the “omics” era 113
Balanced propofol sedation administered by nonanesthesiologists : the first Italian experience 112
The Endoscopic Management of Anastomotic Strictures After Esophagogastric Surgery: A Comprehensive Review of Emerging Approaches Beyond Endoscopic Dilation 109
Autonomic nervous system dysregulation in irritable bowel syndrome 104
Prevalence of Germline Mutations in Cancer Predisposition Genes in Patients with Pancreatic Cancer or Suspected Related Hereditary Syndromes: Historical Prospective Analysis 100
Endoscopic Management of Post-Esophagectomy Delayed Gastric Conduit Emptying (DGCE): Results from a Cohort Study in a Tertiary Referral Center with Comparison between Procedures 100
A Prospective Comparison Between Computerized Tomography (CT) and Magnetic Resonance (MR) in Ileo-Colonic Crohn's Disease: A Single-Center Experience 98
Advances in Endo-Hepatology: The Role of Endoscopic Ultrasound in the Management of Portal Hypertension 93
Bacterial sensor triggering receptor expressed on myeloid cells-2 regulates the mucosal inflammatory response 93
A PROSPECTIVE, SINGLE CENTER STUDY OF ENDOSCOPIC SUBMUCOSAL DISSECTION OF RECTAL LST LESIONS > 3 CM BY USING AN INNOVATIVE CONCEPT OF INJECTING AND CUTTING: THE WATER-JET HYBRID-KNIFE (ESD-H) 92
Endoscopic Submucosal Dissection (ESD) for the Management of Fibrotic Non-Lifting Colorectal Lesions (NLCLs): Results from a Large Multicenter Retrospective Study 91
Activation of the VEGFC/VEGFR3 Pathway Induces Tumor Immune Escape in Colorectal Cancer 88
A Prospective Comparison Between 1.5t Magnetic Resonance and 3t Magnetic Resonance in Ileo-Colonic Crohn's Disease: A Single Center Experience 86
Internet use among inflammatory bowel disease patients: an Italian multicenter survey 84
Brain cholecystokinin depletion in rats with acute liver failure 83
Biological agents for ulcerative colitis : Hypes and hopes 83
Targeting inflammation to prevent severe acute pancreatitis: NSAIDs are not the holy grail 82
Calcium supplementation for the prevention of colorectal adenomas: a systematic review and meta-analysis of randomized controlled trials 81
WallFlex colonic stent placement for management of malignant colonic obstruction : a prospective study at two centers 80
Balanced Propofol Sedation (BPS) Administered by Non-Anesthesiologists vs Midazolam Alone for Endoscopic Procedure in Patients With IBD: A Single Center Open-Label Trial 77
The Chemokine Receptor CX3CR1 Is Involved in the Neural Tropism and Malignant Behavior of Pancreatic Ductal Adenocarcinoma 74
Bowel damage as assessed by the Lémann Index is reversible on anti-TNF therapy for Crohn's disease 73
Transforming Gastrointestinal Diagnosis with Molecular Endoscopy: Challenges and Opportunities 72
Unique role of junctional adhesion molecule-A in maintaining mucosal homeostasis in inflammatory bowel disease 72
Anti-adhesion molecule therapies in inflammatory bowel disease: touch and go 72
The Role of Therapeutic Endoscopic Ultrasound in Management of Malignant Double Obstruction (Biliary and Gastric Outlet): A Comprehensive Review with Clinical Scenarios 70
Balanced propofol sedation in patients undergoing EUS-FNA: A pilot study to assess feasibility and safety 70
Abdominal cocoon or idiopathic encapsulating peritoneal sclerosis: Magnetic resonance imaging 69
A case of esophageal squamous cell intraepithelial neoplasia with positivity for type 16 human papillomavirus successfully treated with radiofrequency ablation 68
Adalimumab is effective in achieving clinical and endoscopic long-term deep remission : a case report 68
Hereditary or sporadic polyposis syndromes 67
Corrigendum to “Canonical and uncanonical pathogenic germline variants in colorectal cancer patients by next-generation sequencing in a European referral center”: [ESMO Open 7 (2022) 100607] (ESMO Open (2022) 7(6), (S205970292200237X), (10.1016/j.esmoop.2022.100607)) 67
Infliximab therapy inhibits inflammation-induced angiogenesis in the mucosa of patients with Crohn's disease 65
Cytapheresis in inflammatory bowel diseases: Current evidence and perspectives 65
VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis 64
Narrow-band imaging endoscopy to assess mucosal angiogenesis in inflammatory bowel disease: a pilot study 64
Interleukin-6 receptor blocking with intravenous tocilizumab in COVID-19 severe acute respiratory distress syndrome: A retrospective case-control survival analysis of 128 patients 63
Achalasia with dense eosinophilic infiltrate responds to steroid therapy 63
Laparoscopic surgery in rectal cancer : a prospective analysis of patient survival and outcomes 63
Treatment with a Urokinase Receptor-derived Cyclized Peptide Improves Experimental Colitis by Preventing Monocyte Recruitment and Macrophage Polarization 63
Prognostic and predictive cross-roads of microsatellite instability and immune response to colon cancer 63
Adalimumab in ulcerative colitis: Hypes and hopes 61
Endoscopic submucosal dissection in patients with early esophageal squamous cell carcinoma: results from a prospective Western series 61
Multiple pathogenic roles of microvasculature in inflammatory bowel disease : a Jack of all trades 61
The bacterial sensor Triggering Receptor Expressed on Myeloid cells 2 (TREM-2) is a crucial pathogenic mediator in inflammatory bowel disease (IBD) 61
Pneumatic dilation versus laparoscopic heller's myotomy for idiopathic achalasia 60
SELF-EXPANDABLE BIODEGRADABLE STENT IN THE MANAGEMENT OF REFRACTORY BENIGN COLORECTAL STRICTURES: PRELIMINARY RESULTS FROM A PILOT STUDY 60
MFSD2A Promotes Endothelial Generation of Inflammation-resolving Lipid Mediators and Reduces Colitis in Mice 60
MRI in Crohn's disease : current and future clinical applications 60
Colon Staining Efficacy of Methylene Blue MMx (R) 25 mg Modified Release Tablets, Administered As Single Ascending Oral Doses of 150 and 200 mg in Outpatients Colonoscopy 60
Reflux events after laparoscopic heller myotomy with dor fundoplication (HM plus Dor) in achalasia patients using multichannel intraluminal impedance (MII)-pH recordings 59
Italian consensus guidelines for chronic pancreatitis 59
MRE Findings at Crohn's Disease Diagnosis: Disease Activity, Bowel Damage and Predictive Value for Long-Term Outcomes 59
Review article: anti-fibrotic agents for the treatment of Crohn's disease - lessons learnt from other diseases 58
Tumour-associated macrophages as treatment targets in oncology 57
Enhanced platelet adhesion induces angiogenesis in intestinal inflammation and inflammatory bowel disease microvasculature 57
Endoclipping for gastric perforation secondary to second session of EMRC in locally residual early gastric cancer : a case report 57
Pancreatic polypeptide response to food and cerulein in patients with total gastrectomy 56
Effect of Immunosuppression on Immune Response to Pneumococcal Vaccine in Inflammatory Bowel Disease: A Prospective Study 56
Effect of Oral Administration of Methylene Blue MMx (R) Tablets on Double-Stranded DNA Damage Assessed by gamma H2AX Analysis of Colon Biopsy Samples - A Single Center, Open Label, Safety, Phase II Study 56
How dense, how intense? Role of tumour-infiltrating lymphocytes across colorectal cancer stages. Re: Nosho et al. Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: Cohort study and literature review. J Pathol 2010; 222: 350-366 55
Epithelial to mesenchymal transition: A challenging playground for translational research. current models and focus on TWIST1 relevance and gastrointestinal cancers 55
Impact of Tumour Necrosis Factor Antagonists on Avoiding Surgery in Stricturing Crohn's Disease: A Tertiary Center Real-Life Experience 55
The role of MAPK in governing lymphocyte adhesion to and migration across the microvasculature in inflammatory bowel disease 55
Step-up and top-down approaches to the treatment of Crohn’s disease: early may already be too late 55
Successful induction of clinical response and remission with certolizumab pegol in Crohn's disease patients refractory or intolerant to infliximab: a real-life multicenter experience of compassionate use 55
Endoscopic mucosal resection for early colorectal neoplasia: pathologic basis, procedures, and outcomes 54
Endoluminal fundoplication (ELF) for GERD using esophyX : a 12-Month follow-up in a single-center experience 53
Impact of Medications on Radiologic Disease Activity and Bowel Damage in Crohn's Disease: A Prospective Longitudinal MRI Study 53
The atypical chemokine receptor D6 controls intestinal inflammation and inflammation-associated colon cancer 53
Emerging biologics in the treatment of inflammatory bowel disease : what is around the corner? 53
Combination of Laparoscopy and Enhanced Recovery Program Improves Outcomes After Ileocecal Resection for Crohn's Disease 52
Clinical experience with a new endoscopic over-the-scope clip system for use in the GI tract 52
Comparison between 1.5 and 3.0 Tesla magnetic resonance enterography for the assessment of disease activity and complications in ileo-colonic Crohn's disease 52
Transoral treatment of Zenker diverticulum : flexible endoscopy versus endoscopic stapling. A retrospective comparison of outcomes 51
The lymphatic system controls intestinal inflammation and inflammation-associated colon cancer through the chemokine decoy receptor D6 51
Colorectal cancer screening: dying en route? 51
Review article: anti TNF-alpha induced psoriasis in patients with inflammatory bowel disease 51
Metal stents for malignant colorectal obstruction 51
Mucosal healing in ulcerative colitis: Where do we stand? 51
LIAISON® Calprotectin for the prediction of relapse in quiescent ulcerative colitis: The EuReCa study 50
Value of Preoperative Magnetic Resonance Enterography to Predict Surgical Findings and to Guide Decisions in Crohn's Disease: A Prospective Study 50
New insights into inflammatory bowel disease pathophysiology: Paving the way for novel therapeutic targets 50
Oral Beclomethasone: A Review of its Use in Inflammatory Bowel Disease 50
Leukocyte traffic control: a novel therapeutic strategy for inflammatory bowel disease 50
The role of acid in functional dyspepsia 50
Dysfunctional Extracellular Matrix Remodeling Supports Perianal Fistulizing Crohn′s Disease by a Mechanoregulated Activation of the Epithelial-to-Mesenchymal Transition 49
Efficacy and safety of biodegradable stents for refractory benign esophageal strictures: The BEST (Biodegradable Esophageal Stent) study 49
Genetic and epigenetic alterations in primary colorectal cancers and related lymph node and liver metastases 48
Gastroenterology department operational reorganisation at the time of covid-19 outbreak: an Italian and Chinese experience 48
Effects of immunosuppression on immune response to pneumococcal vaccine in inflammatory bowel disease : a prospective study 48
Totale 9.198
Categoria #
all - tutte 55.177
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.177


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022110 0 0 0 99 2 3 0 0 0 2 0 4
2022/2023516 237 111 15 0 1 58 3 17 56 4 1 13
2023/2024244 16 8 12 18 23 31 25 30 3 18 8 52
2024/20251.846 149 7 31 28 27 96 525 145 233 319 131 155
2025/20268.862 489 583 587 1.014 516 187 507 475 1.981 359 1.287 877
2026/2027121 121 0 0 0 0 0 0 0 0 0 0 0
Totale 11.700